Quisinostat
Quisinostat
Quisinostat (pronunciation: kwi-si-no-stat) is a type of histone deacetylase inhibitor used in the treatment of various types of cancer. It is currently in the experimental phase and is not yet approved for general use.
Etymology
The term "Quisinostat" is derived from the Latin word "quisin", meaning "to seek", and "stat", a common suffix in drug nomenclature that implies inhibition or stopping. Thus, the term "Quisinostat" can be interpreted as "seeking to stop".
Usage
Quisinostat is used in the treatment of various types of cancer, including breast cancer, prostate cancer, and lung cancer. It works by inhibiting the activity of histone deacetylases, enzymes that are involved in the regulation of gene expression. By inhibiting these enzymes, Quisinostat can alter the expression of genes that are involved in the growth and proliferation of cancer cells, thereby slowing down or stopping the progression of the disease.
Related Terms
- Histone deacetylase inhibitor: A class of drugs that inhibit the activity of histone deacetylases, enzymes that are involved in the regulation of gene expression.
- Cancer: A group of diseases characterized by the uncontrolled growth and spread of abnormal cells.
- Breast cancer: A type of cancer that forms in the cells of the breasts.
- Prostate cancer: A type of cancer that occurs in the prostate, a small walnut-shaped gland in men that produces the seminal fluid that nourishes and transports sperm.
- Lung cancer: A type of cancer that begins in the lungs.
External links
- Medical encyclopedia article on Quisinostat
- Wikipedia's article - Quisinostat
This WikiMD dictionary article is a stub. You can help make it a full article.
Languages: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
Urdu,
বাংলা,
తెలుగు,
தமிழ்,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
European
español,
Deutsch,
français,
русский,
português do Brasil,
Italian,
polski